Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass by Reducing Cardiac Endothelial Permeability

NCT05534802 is registered in ClinicalTrials.gov with Qin Zhang as lead sponsor.

NCT NCT05534802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05534802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass by Reducing Cardiac Endothelial Permeability
Lead sponsor
Qin Zhang
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2022
Completion date
December 30, 2024
Enrollment
236 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacological action